According to United Therapeutics's latest financial reports the company has $2.99 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $2.99 B | 5.47% |
2022-12-31 | $2.83 B | 47.03% |
2021-12-31 | $1.93 B | 5.22% |
2020-12-31 | $1.83 B | 23.49% |
2019-12-31 | $1.48 B | 4.94% |
2018-12-31 | $1.41 B | 52.67% |
2017-12-31 | $0.92 B | -11.74% |
2016-12-31 | $1.05 B | 10.17% |
2015-12-31 | $0.95 B | 37.13% |
2014-12-31 | $0.69 B | 0.24% |
2013-12-31 | $0.69 B | 44.8% |
2012-12-31 | $0.47 B | 18.77% |
2011-12-31 | $0.40 B | -35.66% |
2010-12-31 | $0.62 B | 173.25% |
2009-12-31 | $0.22 B | -2.78% |
2008-12-31 | $0.23 B | -18.62% |
2007-12-31 | $0.29 B | 27.36% |
2006-12-31 | $0.22 B | 81.5% |
2005-12-31 | $0.12 B | 51.58% |
2004-12-31 | $82.78 M | 20.75% |
2003-12-31 | $68.56 M | -44.1% |
2002-12-31 | $0.12 B | 118.83% |
2001-12-31 | $56.05 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $12.69 B | 323.83% | ๐บ๐ธ USA |
Eli Lilly LLY | $2.92 B | -2.22% | ๐บ๐ธ USA |
Baxter BAX | $3.19 B | 6.68% | ๐บ๐ธ USA |
Gilead Sciences GILD | $7.26 B | 142.61% | ๐บ๐ธ USA |
Cardinal Health CAH | $4.59 B | 53.33% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $6.35 B | 112.24% | ๐ฌ๐ง UK |
Cytokinetics
CYTK | $0.61 B | -79.47% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $3.22 B | 7.75% | ๐ฎ๐ฑ Israel |